Anti Transcription Intermediary Factor 1gamma Antibody Positivity C5676701
This antibody is found in some dermatomyositis patients and indicates higher cancer risk. Adults with this antibody require regular cancer screening. Management focuses on immune suppression and treating any detected malignancies.
Key facts at a glance
- ICD-10
- M35.9
- ICD-11
- FA00.0
- Body system
- musculoskeletal
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Shortness of breath
Joint pain or stiffness
(musculoskeletal)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Proximal muscle weakness
(musculoskeletal)Heliotrope rash
(musculoskeletal)Joint pain
(musculoskeletal)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Azathioprine
Azathioprine provides long-term immunosuppression for anti-TIF1-gamma antibody positivity, reducing inflammatory activity and preventing disease flares. It serves as a steroid-sparing alternative for maintenance therapy.
Drug therapy and clinical monitoring
Active treatment with regular monitoring by a healthcare provider is recommended.
Comprehensive malignancy surveillance
Regular monitoring for associated malignancies is critical given the strong paraneoplastic association. Surveillance includes imaging, tumor markers, and age-appropriate cancer screenings at recommended intervals.
Additional treatment options
Mycophenolate mofetil
Mycophenolate mofetil inhibits lymphocyte proliferation and provides effective immunosuppression for dermatomyositis. This agent is particularly useful for refractory skin and muscle involvement.
medicationAnti-inflammatory nutrition
An anti-inflammatory diet rich in omega-3 fatty acids, antioxidants, and fruits and vegetables may support overall immune function. Dietary modifications complement medical therapy for optimal outcomes.
dietaryPsychological support services
Mental health support addresses anxiety, depression, and adjustment difficulties common in chronic autoimmune conditions. Cognitive-behavioral therapy and support groups improve quality of life and coping strategies.
psychologicalWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Anti Transcription Intermediary Factor 1gamma Antibody Positivity C5676701?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Dufner V, Schmidt E. European Dermatology Forum guideline on autoimmune connective tissue diseases. J Eur Acad Dermatol Venereol. 2022;36(Suppl 3):1-25.
Fujimoto M, Hamaguchi Y, Takehara K. Clinical significance of myositis-specific autoantibodies in idiopathic inflammatory myopathies. Curr Opin Rheumatol. 2020;32(5):405-413.
Tiniakou E, Pinal-Fernandez I, Albayda J. Anti-TIF1-gamma antibodies and cancer in patients with dermatomyositis: a retrospective cohort study. Arthritis Rheumatol. 2021;73(8):1450-1458.
Oldroyd A, New RP, Lilleker J. Myositis-specific and myositis-associated autoantibodies: a narrative review. Rheumatology (Oxford). 2023;62(1):14-26.
Medication Comparisons
Compare medications used to treat Anti Transcription Intermediary Factor 1gamma Antibody Positivity C5676701. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy